SCI Pharmtech (Taiwan) Buy Hold or Sell Recommendation
| 4119 Stock | TWD 95.50 2.10 2.15% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding SCI Pharmtech is 'Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell SCI Pharmtech given historical horizon and risk tolerance towards SCI Pharmtech. When Macroaxis issues a 'buy' or 'sell' recommendation for SCI Pharmtech, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out SCI Pharmtech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as SCI and provide practical buy, sell, or hold advice based on investors' constraints. SCI Pharmtech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
SCI |
Execute SCI Pharmtech Buy or Sell Advice
The SCI recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on SCI Pharmtech. Macroaxis does not own or have any residual interests in SCI Pharmtech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute SCI Pharmtech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
SCI Pharmtech Trading Alerts and Improvement Suggestions
| About 49.0% of the company shares are owned by insiders or employees |
SCI Pharmtech Returns Distribution Density
The distribution of SCI Pharmtech's historical returns is an attempt to chart the uncertainty of SCI Pharmtech's future price movements. The chart of the probability distribution of SCI Pharmtech daily returns describes the distribution of returns around its average expected value. We use SCI Pharmtech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of SCI Pharmtech returns is essential to provide solid investment advice for SCI Pharmtech.
| Mean Return | 0.12 | Value At Risk | -0.67 | Potential Upside | 1.34 | Standard Deviation | 0.78 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of SCI Pharmtech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
SCI Pharmtech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to SCI Pharmtech or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that SCI Pharmtech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a SCI stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.12 | |
β | Beta against Dow Jones | -0.07 | |
σ | Overall volatility | 0.78 | |
Ir | Information ratio | -0.0084 |
SCI Pharmtech Volatility Alert
SCI Pharmtech exhibits relatively low volatility with skewness of 0.7 and kurtosis of 4.24. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure SCI Pharmtech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact SCI Pharmtech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.SCI Pharmtech Fundamentals Vs Peers
Comparing SCI Pharmtech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze SCI Pharmtech's direct or indirect competition across all of the common fundamentals between SCI Pharmtech and the related equities. This way, we can detect undervalued stocks with similar characteristics as SCI Pharmtech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of SCI Pharmtech's fundamental indicators could also be used in its relative valuation, which is a method of valuing SCI Pharmtech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare SCI Pharmtech to competition |
| Fundamentals | SCI Pharmtech | Peer Average |
| Return On Equity | 0.0609 | -0.31 |
| Return On Asset | 0.0077 | -0.14 |
| Profit Margin | 0.26 % | (1.27) % |
| Operating Margin | 0.07 % | (5.51) % |
| Current Valuation | 9.19 B | 16.62 B |
| Shares Outstanding | 95.38 M | 571.82 M |
| Shares Owned By Insiders | 48.80 % | 10.09 % |
| Shares Owned By Institutions | 0.77 % | 39.21 % |
| Price To Earning | 14.98 X | 28.72 X |
| Price To Book | 2.62 X | 9.51 X |
| Price To Sales | 11.33 X | 11.42 X |
| Revenue | 864.22 M | 9.43 B |
| Gross Profit | 208.09 M | 27.38 B |
| EBITDA | 129.25 M | 3.9 B |
| Net Income | 55.7 M | 570.98 M |
| Cash And Equivalents | 1.01 B | 2.7 B |
| Cash Per Share | 12.73 X | 5.01 X |
| Total Debt | 3.65 M | 5.32 B |
| Debt To Equity | 0.10 % | 48.70 % |
| Current Ratio | 3.24 X | 2.16 X |
| Book Value Per Share | 37.30 X | 1.93 K |
| Cash Flow From Operations | 280.28 M | 971.22 M |
| Earnings Per Share | 2.13 X | 3.12 X |
| Target Price | 86.0 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | -0.0933 | -0.15 |
| Market Capitalization | 9.59 B | 19.03 B |
| Total Asset | 4.19 B | 29.47 B |
| Retained Earnings | 809 M | 9.33 B |
| Working Capital | 1.02 B | 1.48 B |
| Current Asset | 1.8 B | 9.34 B |
| Current Liabilities | 782 M | 7.9 B |
| Annual Yield | 0.01 % |
SCI Pharmtech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as SCI . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About SCI Pharmtech Buy or Sell Advice
When is the right time to buy or sell SCI Pharmtech? Buying financial instruments such as SCI Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having SCI Pharmtech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 77 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for SCI Stock Analysis
When running SCI Pharmtech's price analysis, check to measure SCI Pharmtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCI Pharmtech is operating at the current time. Most of SCI Pharmtech's value examination focuses on studying past and present price action to predict the probability of SCI Pharmtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCI Pharmtech's price. Additionally, you may evaluate how the addition of SCI Pharmtech to your portfolios can decrease your overall portfolio volatility.